Bandim Health Project

Bandim Health Project
Projecto de Saúde Bandim
AbbreviationBHP
Formation1978
FounderPeter Aaby
TypeNon-governmental organization
Location
MembershipThe INDEPTH Network
Leader
Peter Aaby
National Research Coordinator
Amabélia Rodrigues
Parent organization
Statens Serum Institut
AffiliationsUniversity of Southern Denmark
Center for Vitamins and Vaccines
Centre for International Health
Copenhagen University
Aarhus University
Staff150
Websitewww.bandim.org

The Bandim Health Project works with population based health research in one of the world's poorest countries, Guinea-Bissau in West Africa.

Group members have made strong claims about the non-specific effect of vaccines, but these claims have been described as the result of questional research methods.[1]

11°50′43.64″N 15°35′45.42″W / 11.8454556°N 15.5959500°W / 11.8454556; -15.5959500

History

[edit]

The Bandim Health Project was initiated in 1978 by Peter Aaby. The project is currently based on collaboration between the Ministry of Public Health in Guinea-Bissau, the Statens Serum Institut in Denmark, and researchers affiliated to The University of Southern Denmark, as well as the University of Aarhus, Denmark.[citation needed]

In 2012, the Danish National Research Foundation funded the establishment of the Center of Excellence, The Research Center for Vitamins and Vaccines (CVIVA) based on the Bandim Health Project and its research into non-specific effects of vaccines.[citation needed]

Fields of research

[edit]

The Bandim Health Project works with population based health research, focusing on women and children. The project's fields of research include:[citation needed]

Questionable research practice

[edit]

A 2025 article in Vaccine said that strong claims made by Benn and Aaby about non-specific vaccine effects were not supported by the evidence presented: "We were surprised to find several instances of questionable research practices, such as unpublished primary outcomes, outcome switching, reinterpretation of trials based on statistically fragile subgroup analyses, and frequent promotion of cherry-picked secondary findings as causal, even when primary outcomes yielded null results. Sample size calculations appeared to be driven by unwarranted optimism regarding effect-sizes and event rates leading to underpowered studies".[1]

The organization

[edit]

The Bandim Health Project is led by Peter Aaby. The National Research Coordinator is Amabélia Rodrigues. Since the project's foundation in 1978, more than 700 scientific articles have been published, and more than 40 PhD or doctoral degrees and 13 Masters of International Health degrees have been obtained by researchers employed by the project.[citation needed]

Affiliations

[edit]

Bandim Health Project is placed in Guinea-Bissau and also has a small department at Statens Serum Institut in Denmark. Bandim Health Project is also affiliated with University of Southern Denmark, where Peter Aaby is an adjunct professor and Christine Benn holds a professorship in Global Health.[citation needed]

See also

[edit]

References

[edit]
  1. ^ a b Støvring H, Ekstrøm CT, Schneider JW, Strøm C (November 2025). "What is actually the emerging evidence about non-specific vaccine effects in randomized trials from the Bandim Health Project?". Vaccine 127937. doi:10.1016/j.vaccine.2025.127937. PMID 41233263.
[edit]